Case Name: Depomed, Inc. v. Actavis Elizabeth LLC, No. 12-1358-JAP, 2014 U.S. Dist. LEXIS 118096 (D.N.J. Aug. 18, 2014) (Pisano, J.) Drug Product and Patent (s)-in-Suit: Gralise® (gabapentin); U ...

> Drug delivery specialist EastGate Acquisitions said that it is trying to acquire the licensing rights to develop and manufacture an intraoral insulin formulation. Release ...

Actavis has another drug recall to deal with, this one involving nearly 65,000 bottles of the generic version of the seizure drug Neurontin that it manufactures at a plant in India. The voluntary ...

The FDA in November 2010 granted once-a-day Gralise, also known as gabapentin, orphan drug status. The FDA approved the drug in January 2011.

If Actavis were allowed to discontinue sales of an older Alzheimer’s pill and steer patients toward a newer version in order to blunt generic competition, the move could cost Medicare Part D as ...

Actavis has been the most active buyer of drug companies since January 2011, making $35.5 billion of purchases, including the Forest acquisition.